Previously, we reported that the FGFR3-TACC3 (F3-T3) fusion gene chimera might be utilized to treat glioma, which highlighted the more or less exact function of the Cas13a-based tool in glioma therapy 18. This evidence concerns the gene FGFR3 and glioma.